005690 fundamentals
PHARMICELL revenue breakdown overview
PHARMICELL revenue for the last year amounted to 65.00 B KRW, the most of which — 62.78 B KRW — came from its highest performing source at the moment, Biochemical, the year earlier bringing 54.57 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought PHARMICELL 45.99 B KRW, and the year before that — 32.97 B KRW.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
17.00 B
34.00 B
51.00 B
68.00 B
Biochemical
Biomedical
Currency: KRW
2017
2018
2019
2020
2021
2022
2023
2024
Biochemical
35.38 B
49.77 B
58.69 B
54.57 B
62.78 B
Biomedical
2.38 B
1.12 B
1.49 B
1.66 B
2.07 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
17.00 B
34.00 B
51.00 B
68.00 B
South Korea
Asia
Europe
United States
Currency: KRW
2017
2018
2019
2020
2021
2022
2023
2024
South Korea
18.63 B
27.39 B
34.41 B
32.97 B
45.99 B
Asia
2.91 B
4.75 B
4.94 B
3.86 B
12.13 B
Europe
6.26 B
6.11 B
5.25 B
7.34 B
5.87 B
United States
9.96 B
12.65 B
15.58 B
12.07 B
864.24 M